BDBM752685 1,8-dimethyl-5-[[(1R)-1-[3-(1,1- difluoro-2-hydroxy-2-methyl- propyl)-2-fluoro- phenyl]ethyl]amino]spiro[pyrrolo[ 3,2-g]phthalazine-3,4''- tetrahydropyran]-2-one::US20250197407, Compound 115

SMILES Cc1nnc(N[C@H](C)c2cccc(C(F)(F)C(C)(C)O)c2F)c2cc3c(cc12)N(C)C(=O)C31CCOCC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752685   

TargetKRas/Son of Sevenless Homolog 1(Human)
Jazz Pharmaceuticals Ireland

US Patent
LigandPNGBDBM752685(1,8-dimethyl-5-[[(1R)-1-[3-(1,1- difluoro-2-hydrox...)
Affinity DataIC50: 6.61nMAssay Description:The capacity of compounds to inhibit SOS1 binding to KRAS-WT (wild-type) was quantified using a FRET-based protein-protein interaction assay. The ass...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent